Showing results (341-350 of 544) with videos related to

Sort By:
Pageof 55
Vaccine: X|August 17, 2021
Priorities for sexually transmitted infection vaccine research and development: Results from a survey of global leaders and representativesKara M Plotnikoff, Robine Donken, Laurie Smith, et al.
Vaccine: X|January 1, 2024
Factors associated with COVID-19 vaccination among healthcare workers in an Algerian University Teaching Hospital: A cross-sectional studyAbdessamad Dali-Ali, Imene Beneddine, Nori Midoun, et al.
Vaccine: X|May 8, 2023
Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, ThailandSayamon Hongjaisee, Kriangkrai Chawansuntati, Patumrat Sripan, et al.
Vaccine: X|February 17, 2023
Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017-2018Angel Vila-Córcoles, Olga Ochoa-Gondar, Cinta de Diego-Cabanes, et al.
Vaccine: X|April 17, 2023
Trust and vaccine hesitancy during the COVID-19 pandemic: A cross-national analysisWill Jennings, Viktor Valgarðsson, Lawrence McKay, et al.
Vaccine: X|March 6, 2023
The Healthy, Immunized Communities Study: A pilot intervention to increase parents' intentions to get vaccines for their middle school childrenWilliam A Calo, Elizabeth A Hivner, Alicia M Hoke, et al.
Vaccine: X|September 28, 2021
Vaccine hesitancy as an opportunity for engagement: A rapid qualitative study of patients and employees in the U.S. Veterans Affairs healthcare systemA Rani Elwy, Marla L Clayman, Lara LoBrutto, et al.
Vaccine: X|May 5, 2022
The potential cost-effectiveness of HPV vaccination among girls in MongoliaMunkh-Erdene Luvsan, Elisabeth Vodicka, Uranbolor Jugder, et al.
Vaccine: X|April 25, 2022
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in IndiaS Mangarule, S Palkar, M Mitra, et al.
Vaccine: X|July 22, 2022
Factors contributing to missed opportunities for human papillomavirus vaccination among adolescents, ages 11 to 13, in IowaGrace W Ryan, Sarah S Perry, Aaron Scherer, et al.
Pageof 55